CCL11 promotes angiogenic activity by activating the PI3K/Akt pathway in HUVECs.

Related Articles

CCL11 promotes angiogenic activity by activating the PI3K/Akt pathway in HUVECs.

J Recept Signal Transduct Res. 2017 Mar 09;:1-6

Authors: Park JY, Kang YW, Choi BY, Yang YC, Cho BP, Cho WG

Abstract
CCR3, the receptor for CCL11, is expressed on the surface of immune cells and even on non-immune cells. CCL11-CCR3 interactions can promote cell migration and proliferation. In this study, we investigated the effect of CCL11 on angiogenesis in HUVECs and also examined the molecular mechanisms of this process. We found that CCL11 induced mRNA transcription and protein expression of CCR3 in HUVECs. Moreover, the scratch wound healing assay and MTS proliferation assay both demonstrated that CCL11 promotes endothelial cell migration and induces weak proliferation. CCL11 directly induced microvessel sprouting from the rat aortic ring; these effects occurred earlier and to a greater extent than with VEGF stimulation. Furthermore, CCL11-induced phosphorylation of Akt was abolished by PI3K inhibitors. siRNA-mediated knockdown of CCR3 led to a significant reduction of PI3K phosphorylation. However, the phosphorylation levels of ERK1/2 were not changed, even after CCL11 treatment. Cumulatively, our data suggest that the CCL11-CCR3 interaction mainly activates PI3K/Akt signal transduction pathway in HUVECs.

PMID: 28279120 [PubMed - as supplied by publisher]

http://ift.tt/2mT6ODj